profit from every $100 of sales.
$0$100
Park Ha Biological Technology Co., Ltd. Ordinary Shares
$1.45-1.36% today
-98.9% in 1 year
1-year low $1.451-year high $139.20
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Park Ha Biological Technology Co., Ltd. Ordinary Shares sold, what it kept, and what it did with the cash.
Sales went from $1.92 million in 2022 to $2.52 million in 2025, with -$24.4 million of profit last year.
SalesProfit
Park Ha Biological Technology Co., Ltd. Ordinary Shares vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Park Ha Biological Technology Co., Ltd. Ordinary Shares | No profit yet | ||
 Rollins | 35.3× · Expensive | ||
 Frontdoor | 25.6× · Fair price | ||
 H&R Block | 8.3× · Cheap | ||
 Bright Horizons Family Solutions | 13.1× · Cheap |
AI analysis
An AI analyst reads Park Ha Biological Technology Co., Ltd. Ordinary Shares's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 2 | 2 | 2 | 3 | |
| 1 | 2 | 2 | 2 | |
| 0 | 1 | 1 | -24 | |
| 0 | 1 | 1 | -24 | |
| 0 | 1 | 0 | -24 | |
| 0.37 | 1.63 | 0.91 | – | |
| 73.5% | 87.4% | 91.8% | 94.4% | |
| 10.3% | 48.0% | 33.3% | -956.5% | |
| 10.0% | 34.6% | 20.1% | -965.0% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 3 | 2 | 3 | 6 |
| Cash | 1 | 1 | 1 | 4 |
| Total debt | 0 | 0 | 0 | 0 |
| Total liabilities | 2 | 1 | 2 | 2 |
| 0 | 1 | 2 | 4 | |
| 1 | 1 | 1 | – | |
| 85.1% | 89.4% | 39.8% | -455.7% | |
| 127.3% | 84.2% | 31.8% | -609.9% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1 | 0 | 1 | 0 | |
| 0 | 0 | 0 | 0 | |
| 1 | 0 | 1 | -0 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| – | 0 | 0 | 24 |
Valuation
- –
- –
- –
- 0.2×
- 11.2×
- –
- –
- -0.0%
- -86.1%
- 0.0%
Profitability
- 94.4%
- -956.5%
- -965.0%
- -952.1%
- -578.4%
- -54.8%
- -591.0%
- -409.3%
- -593.2%
- 9.4%
Growth
- +9.6%
- –
- −100.3%
- –
- +3.0%
Financial health
- -0.2×
- 0.05
- 3.0%
- -588,997.6×
- 2.92
- 2.88
- 0.42
How it ranks in Consumer Discretionary
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 42%of 992
Bottom 15%of 979
News
Six Flags adding seat belts to roller coasters following Georgia park deathSeeking Alpha · Oct 24, 2026Taiwan plans $4 bln Texas park to support Nvidia’s AI supply chain - BloombergYahoo Finance · Oct 16, 2026Latest News In Cloud AI - Park Place Expands Microsoft Cloud Services to North AmericaYahoo Finance · Oct 13, 2026Why Park Aerospace Stock Is Plunging TodayYahoo Finance · Oct 9, 2026She pays $96 a month to live in Yellowstone National Park: 'Being here has changed my life'CNBC · Sep 19, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
37No pass
Benjamin Graham
74Pass
Philip Fisher
46No pass
Peter Lynch
64Pass
Joel Greenblatt
2No pass
Charlie Munger
50No pass
Terry Smith
44No pass
Questions about Park Ha Biological Technology Co., Ltd. Ordinary Shares
Is Park Ha Biological Technology Co., Ltd. Ordinary Shares a good stock to buy?
A business with weak numbers that is not profitable yet. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Park Ha Biological Technology Co., Ltd. Ordinary Shares AI analysis
What does Park Ha Biological Technology Co., Ltd. Ordinary Shares do?
The company is an investment holding company that develops skincare products under the “Park Ha” brand in the People’s Republic of China, through its subsidiaries operating in direct product sales and franchise services. It is in Personal Products & Services.
Does Park Ha Biological Technology Co., Ltd. Ordinary Shares pay a dividend?
No. Park Ha Biological Technology Co., Ltd. Ordinary Shares does not pay a dividend at the moment.
Is Park Ha Biological Technology Co., Ltd. Ordinary Shares stock halal?
Yes. Park Ha Biological Technology Co., Ltd. Ordinary Shares passes our halal screen: its business is permitted and its debt is 0.6% of its market value, under the 30% limit. How we check
How has Park Ha Biological Technology Co., Ltd. Ordinary Shares stock done over the past year?
Down 98.9% over the past twelve months, to $1.45. It traded between $1.45 and $139.20 and is 99.0% below its high.
Who are Park Ha Biological Technology Co., Ltd. Ordinary Shares's competitors?
The largest listed companies in the same industry are Rollins, Frontdoor, H&R Block and Bright Horizons Family Solutions. The peers table on this page compares their profit, growth and price with Park Ha Biological Technology Co., Ltd. Ordinary Shares's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.